Ben Adlin is a Court Reporter at Washington State. He focuses on legal issues surrounding cannabis, criminal justice, and policy reform, with a keen eye on the intersection of law and emerging social trends. His work has been featured in FILTER, Marijuana Moment, and Law360.
Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston
United States (National)
Not enough data
Not enough data
Ben Adlin's coverage primarily focuses on marijuana legalization, drug policy, and cannabis markets in the United States. His articles often include government announcements, legal policy regulations, and cited data. To effectively pitch to Ben Adlin, one should provide insights into the latest developments related to marijuana legalization or drug policy changes in the US. Experts with a deep understanding of regulatory frameworks and market trends within the cannabis industry would likely be valuable sources for his articles. Additionally, providing access to relevant data or studies supporting new healthcare policies or pharmaceutical advancements could also capture Ben's interest due to his focus on healthcare-related topics within the context of drug policy reforms.
This information evolves through artificial intelligence and human feedback. Improve this profile .
By: Ben Adlin
New research published by the American Medical Association (AMA) finds that marijuana and psychedelics “were among a small set of drugs” that showed promise for improving eating disorders.
By: Ben Adlin
A new case study in the journal Veterinary Medicine and Science suggests that very small doses of the psychedelic LSD appeared to ease a dog's severe
By: Ben Adlin
MDMA could be a safe and effective treatment for major depressive disorder (MDD), according to a new study, with participants showing “significantly
By: Ben Adlin
New federally funded research on the relationship between post-traumatic stress disorder and cannabis use in military veterans finds that marijuana
By: Ben Adlin
Medical marijuana has “genuine therapeutic effects for pain management,” and the degree of relief provided by cannabis can be predicted by their
By: Ben Adlin
Psilocybin, a main chemical component in psychedelic mushrooms, could play a beneficial role in patients recovering from traumatic brain injury (TBI), according to a new scientific review published in the journal Brain Science.
By: Ben Adlin
Cannabis seed oil can help accelerate healing of skin wounds—a promising development that authors say indicates that “hemp seed oil may serve as a
By: Ben Adlin
In a recent interview, a Hollywood director recalled the time that famed actor Jeff Bridges gave him a scare by getting high on marijuana right
By: Ben Adlin
A new study reinforces the idea that there are similarities between psychedelics and meditation, with participants who had personally meaningful
By: Ben Adlin
Former U.S. House Speaker Newt Gingrich (R-GA) extolled the therapeutic promise of ibogaine on a recent episode of his podcast, drawing attention to a Stanford University study that found the psychedelic showed potential to treat PTSD, anxiety and depression in military veterans with traumatic brain injury. “This could be one of the great breakthroughs of […]
